In AD research, this approach uncovers how phytochemicals modulate core pathological pathways including Aβ aggregation, tau phosphorylation, oxidative stress, and neuroinflammation via shared molecular targets (Naseri et al., 2019). Here, MAPT is linked to Alzheimer disease.